Clinical researchers at Samsun University are investigating the use of a specialized pain management technique to enhance postoperative outcomes for patients undergoing laparoscopic sleeve gastrectomy (LSG). The trial explores whether the bilateral rectointercostal fascial plane block can significantly reduce pain and opioid use after surgery.
The study, currently recruiting participants, has the potential to reshape postoperative pain protocols for LSG patients.
In this article:
- What is the Rectointercostal Fascial Plane Block?
- Why Does This Trial Matter?
- Expected Outcomes and Safety
- FAQs
- Conclusion
- Disclaimer
- Announcement Line
What is the Rectointercostal Fascial Plane Block?
The bilateral rectointercostal fascial plane block is an advanced regional anesthesia technique aimed at reducing visceral pain post-surgery. It functions by delivering a local anesthetic into the fascial plane surrounding the rectus abdominis muscle and intercostal spaces. This targeted approach directly addresses the nerve pathways stimulated during LSG procedures, offering a possible alternative to heavy opioid use.
Why Does This Trial Matter?
Morbidity associated with obesity continues to rise globally, and laparoscopic sleeve gastrectomy is one of the most effective interventions to combat obesity. However, postoperative pain can be significant, and traditional methods often rely heavily on opioids like morphine, which pose risks of dependency and adverse effects.
By exploring the rectointercostal fascial plane block combined with intravenous patient-controlled analgesia (IV PCA) using minimal morphine doses, the study aims to reduce opioid reliance while managing postoperative discomfort effectively. This could lead to improved patient recovery and satisfaction, aligning with modern medical device regulatory goals of enhancing performance and safety.
Expected Outcomes and Safety
The trial will evaluate the efficacy of bilateral rectointercostal fascial plane block compared to conventional IV PCA with morphine alone. Key metrics include postoperative pain levels measured on a standardized scale, opioid consumption, and potential adverse effects like respiratory depression or sedation.
Samsun University researchers emphasize the trial adheres to strict safety and performance protocols as outlined in regulatory standards. All participants will be closely monitored to ensure compliance with existing safety guidelines.
FAQs
- What is the main goal of the study?
To investigate whether the bilateral rectointercostal fascial plane block can reduce postoperative pain and decrease opioid use in patients undergoing laparoscopic sleeve gastrectomy. - Who is eligible to participate?
Patients undergoing laparoscopic sleeve gastrectomy who meet the study’s screening criteria. - What are the clinical challenges this study addresses?
It tackles opioid dependency and postoperative pain management, which are critical concerns in obesity-related surgical procedures.
Conclusion
Innovating postoperative care is vital, especially for patients undergoing prevalent procedures like LSG. Samsun University’s trial highlights the importance of exploring advanced techniques such as the bilateral rectointercostal fascial plane block to improve recovery outcomes safely and effectively.
Healthcare professionals and regulatory bodies should monitor this study closely for insights into pain management advancements in surgical interventions.
Disclaimer
This publication is intended for professional audiences. It does not constitute legal or clinical advice and relies on the source text and referenced materials for the basis of claims made.
Announcement Line
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07253610?term=medical+device